Why the Medicare Specialty Threshold Shouldn’t Drive Pricing Strategy

Triangle Insights Group

Why the Medicare Specialty Threshold Shouldn’t Drive Pricing Strategy

White Paper

White Paper Why the Medicare Specialty Threshold Shouldn’t Drive Pricing Strategy

The Medicare specialty threshold is commonly touted as an important factor that could have implications for not only the Medicare channel but also the commercial book of business. We argue that while the specialty threshold can be a key consideration for a minority of therapeutics, using the threshold as a “de facto” decision point is ill-advised for most products.

Download Whitepaper
Skip to toolbar